Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.

Key Terms

propylene glycol-based coolant medical

A propylene glycol-based coolant is a liquid used to transfer heat and prevent freezing in equipment, functioning like antifreeze for machines and systems. Investors should care because its safety profile, cost, availability and regulatory treatment influence operating expenses, product choices and liability or environmental risk for companies that rely on large cooling systems or battery thermal management.

adverse events medical

Adverse events are any harmful or unwanted medical occurrences experienced by people using a drug, device, or undergoing a treatment, whether or not the problem is caused by the product. Think of them as complaints or breakdowns noticed during a trial or after a product is on the market; regulators record and investigate them. Investors care because clusters or serious adverse events can delay approvals, trigger costly studies or recalls, change labeling, and quickly alter a company’s revenue and risk profile.

u.s. food and drug administration (fda) regulatory

The U.S. Food and Drug Administration (FDA) is a government agency responsible for protecting public health by ensuring the safety and effectiveness of food, medicines, vaccines, and other health-related products. For investors, the FDA’s decisions can significantly impact companies in the healthcare and food industries, as approval or rejection of products can influence a company's success and stock performance.

medwatch adverse event reporting program regulatory

MedWatch is the U.S. Food and Drug Administration’s public system for collecting reports about harmful effects, side effects, or problems with drugs, medical devices, and other medical products. Investors care because clusters of reports can signal safety problems that lead to sales declines, product recalls, regulatory action, or lawsuits—events that can quickly change a company’s revenue outlook; think of it as a neighborhood tip line that alerts authorities to emerging dangers.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARREN, N.J.--(BUSINESS WIRE)-- Haleon (NYSE: HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer level. The lots are being recalled due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.

Gas-X Extra Strength Softgels (120 ct.) Front of Carton

There is a potential that ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse events such as nausea, vomiting, abdominal pain and diarrhea.

To date, Haleon has not received any reports of adverse events related to this recall.

Gas-X Extra Strength Softgels are indicated to quickly break up gas bubbles in the digestive tract and relieve pressure, bloating, and discomfort. Gas-X Extra Strength Softgels are uniquely identified as a green capsule and found in packaging with a green band. Only the lots in the table below are impacted. No other lots of Gas-X Extra Strength, Gas-X Ultra, Gas-X Maximum and Gas-X Ultimate are impacted by this recall.

Product	UPC	Lot Number	Expiry Date	Dates of Distribution
Gas-X Extra Strength Softgels (120 ct.)	300674350419	TL8K YH9X YH9Y	30 Nov 2028 30 Nov 2028 30 Nov 2028	13 Apr 2026 – 05 May 2026
Gas-X Extra Strength Softgels (72 ct.)	300439005721	X78N	30 Nov 2028	05 May 2026 – 14 May 2026

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

Haleon is notifying its distributors and customers by letter, email, and phone notification, and is arranging for the return of all recalled products.

Consumers who have purchased Gas-X Extra Strength Softgels on or after April 13, 2026, should review the lot number. If the lot number matches those impacted by this recall, stop taking the product immediately and contact the Haleon Consumer Relations team at +1-800-245-1040 (Monday through Friday 8 a.m. to 6 p.m. ET), or via mystory.us@haleon.com or https://haleon.help/en-us/contact-form to arrange for return of the product and request reimbursement.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. They should also report any adverse events to our Consumer Relations Team at +1-800-245-1040 (Monday through Friday 8 a.m. to 6 p.m. ET) or via mystory.us@haleon.com or https://haleon.help/en-us/contact-form.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm.
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.

Consumer safety and product quality are our utmost priorities at Haleon. The root cause of the contamination has been identified and repaired. Corrective and preventative actions have been implemented to prevent future recurrence.

About Haleon

Haleon (LSE/NYSE: HLN) is a globally leading consumer company that is solely focused on better everyday health. Haleon's product portfolio spans three major categories - Oral Health, Over-the-Counter (OTC), and Wellness. Its long-standing brands - such as Advil, Centrum, Parodontax, Sensodyne, Theraflu, and TUMS - are built on trusted science, innovation and deep human understanding. For more information on Haleon and its brands, please visit www.haleon.com or contact USMediaRelations@haleon.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604056780/en/

Media Contact:
USMediaRelations@haleon.com
1-800-245-1040

Source: Haleon